Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CXCR4 | P61073 | 1/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | MAPK9 | P45984 | 1/20 | 0.46 |
| ▸ | MAPK10 | P53779 | 1/20 | 0.46 |
| ▸ | CALCR | P30988 | 4/20 | 0.45 |
| ▸ | CALCRL | Q16602 | 1/20 | 0.45 |
| ▸ | NMUR2 | Q9GZQ4 | 1/20 | 0.43 |
| ▸ | NMUR1 | Q9HB89 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.43 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.43 |
| ▸ | F2R | P25116 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31018335 | 0.99 | CXCR4 (0.48) | CXCR4MAPK8MAPK9MAPK10CALCR | |
| SCHEMBL31018315 | 0.94 | NMUR2 (0.49) | CXCR4MAPK8MAPK9MAPK10CALCR | |
| SCHEMBL31018319 | 0.93 | CAPN1 (0.49) | CXCR4MAPK8MAPK9MAPK10CALCR | |
| SCHEMBL31018310 | 0.91 | CAPN1 (0.50) | CXCR4MAPK8MAPK9MAPK10CALCR | |
| SCHEMBL31018312 | 0.91 | CALCR (0.55) | CALCRCALCRLOPRM1OPRD1OPRK1 | |
| SCHEMBL30811213 | 0.89 | NMUR2 (0.48) | CXCR4NMUR2NMUR1OPRM1F2R | |
| SCHEMBL31018317 | 0.89 | SLC6A2 (0.53) | MAPK8MAPK9MAPK10CALCRCALCRL | |
| SCHEMBL31018333 | 0.85 | CALCR (0.55) | CALCRNMUR2NMUR1OPRM1OPRD1 | |
| SCHEMBL29649236 | 0.85 | CALCR (0.55) | CXCR4MAPK8MAPK9MAPK10CALCR | |
| SCHEMBL32690479 | 0.84 | F2 (0.47) | NMUR2NMUR1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112891512-B | Use of polypeptide compounds for preventing or treating liver fibrosis | 清远市图微安创科技开发有限公司 | 2024-07-26 | — | — | CN | disclosed |